FDA warns seniors to avoid this vaccine after deadly complications

Older adults are being warned against receiving the chikungunya vaccine earlier traveling.

The Ixchiq vaccination, developed by Valneva to forestall the mosquito-borne chikungunya virus, was approved by the Food and Drug Administration (FDA) successful November 2023 arsenic the archetypal of its kind.

The support applies to anyone aged 18 and older who has a hazard of being exposed to the virus.

FIRST VACCINE FOR CHIKUNGUNYA VIRUS, AN ‘EMERGING GLOBAL HEALTH THREAT,’ GETS FDA APPROVAL

But the FDA and the Centers for Disease Control and Prevention (CDC) released a information announcement connected May 9 recommending that adults implicit 60 years old intermission usage of the vaccine owed to fatal complications.

"FDA and CDC volition proceed the valuation of post-marketing information reports for Ixchiq," the merchandise reads. 

Older adults are being warned against receiving the chikungunya vaccine earlier traveling. (iStock)

"While the information of Ixchiq for usage successful individuals 60 years of property and older is being further assessed, FDA and CDC are recommending a intermission successful usage of the vaccine successful this property group. FDA and CDC volition update the nationalist erstwhile the agencies implicit their valuation of this information issue."

The advisory follows reports of "serious adverse events," including neurologic and cardiac events successful radical who received the vaccine.

CLICK HERE TO GET THE FOX NEWS APP    

Two of 17 events resulted successful decease from terrible complications. One decease was caused by encephalitis, oregon inflammation successful the brain, the alert stated.

Those who experienced adverse effects of the vaccine were reported to beryllium betwixt the ages of 62 and 89.

A diligent infected with chikungunya looks retired from mosquito netting astatine the Clinicas Hospital successful San Lorenzo, Paraguay, successful March 2023. The FDA warned that Ixchiq, which contains a live, weakened mentation of the virus, whitethorn origin akin symptoms to chikungunya. (AP Photo/Jorge Saenz)

The FDA warned that Ixchiq, which contains a live, weakened mentation of chikungunya, whitethorn origin symptoms akin to the virus.

Typical symptoms of chikungunya see fever, terrible associated pain, headache, musculus symptom and a rash, according to the CDC. 

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Most radical retrieve wrong a week, but immoderate whitethorn acquisition "severe and disabling" associated symptom for weeks oregon months. 

Chikungunya is dispersed by the wound of infected mosquitoes. (iStock)

"This microorganism is successful a akin class arsenic dengue oregon Zika and is carried by the same mosquitoes," Fox News elder aesculapian expert Dr. Marc Siegel antecedently told Fox News Digital.

At the clip of the vaccine's approval, the FDA described chikungunya arsenic an "emerging planetary health threat," with astatine slightest 5 cardinal cases reported implicit the past 15 years. 

For much Health articles, visit www.foxnews.com/health

The FDA plans to behaviour an "updated benefit-risk assessment" for Ixchiq usage successful those implicit 60 years of age, according to the notice.

Fox News Digital's Melissa Rudy contributed to this report.